Agoracom: Small Cap Investment - Zenith Epigenetics - Re: Sabizabulin

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

KOO-KOO2

Rank: Treasurer [?]

Points: 10553 [?]

Votes: 39 Score: 2.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Sabizabulin - mCRPC- used now for Covid 19.

in response to

Re: Sabizabulin - mCRPC- used now for Covid 19.

Nextblockbuster

posted on Apr 24, 2022 11:50AM

BP by way of the several collaborations that are ongoing will need to know one way or another that ZEN-3694 works for them. So as I see it that needs to happen for any one of them to put a bid on Zenith, otherwise, they would have done it already.